source
- Former Pfizer chemist launches Khartis Therapeutics with $95M to develop oral thyroid eye disease drugRobert Hoffman, a veteran Pfizer chemist who previously co‑founded XinThera, announced the launch of Khartis Therapeutics. The new company, formed in 2024 with other former XinThera leaders, aims t…
- WHO and DRC move to fast-track Phase 3 Ebola vaccine trial, starting with Merck’s ErveboThe World Health Organization and authorities in the Democratic Republic of the Congo are negotiating to speed up the launch of a multi‑armed Phase 3 trial of Ebola vaccines. The effort targets th…